Print ISSN:-2394-4781

Online ISSN:-2394-4994

CODEN : IJCACT




Downlaod Files

   


Article Access statistics

Viewed: 1632

PDF Downloaded: 692


Role of IV Nalbuphine in attenuation of haemodynamic response to laryngoscopy and endotracheal intubation


Full Text PDF


Original Article

Author Details : Dnyaneshwar Ramaji Fating, Ashwini K. Dandekar, N.G. Tirpude

Volume : 3, Issue : 2, Year : 2016

Article Page : 165-169


Suggest article by email

Get Permission

Abstract

Background: Laryngoscopy and endotracheal intubation evoke a haemodynamic response leading to increased heart rate and blood pressure. Purpose of present study was to evaluate the efficacy of Nalbuphine for attenuation of haemodynamic response to laryngoscopy and intubation.
Methods: 120 patients belonging to ASA Grade I and II, posted for elective laparoscopic surgery under general anaesthesia were included in this double blind prospective randomised study. Patients were randomly allocated in two groups to receive either injection Nalbuphine IV 0.2mg/kg diluted to 5 ml with normal saline (Group N) or 5 ml normal saline (Group C), five minutes before induction. Monitoring of heart rate, systolic blood pressure, diastolic blood pressure and mean arterial blood pressure was done at laryngoscopy and endotracheal intubation and 1, 3, 5, 7 and 10 minutes after laryngoscopy and endotracheal intubation.
Results: Increase in heart rate, systolic blood pressure, diastolic blood pressure, mean arterial blood pressure in Group N was lower than in Group C.
Conclusion: Intravenous Nalbuphine in the dose of 0.2 mg/kg appears to be a promising drug which can be used to attenuate the haemodynamic response to laryngoscopy and intubation.

Keywords: Nalbuphine, Haemodynamic response, Laryngoscopy, Intubation, Heart Rate and Mean arterial blood pressure



How to cite : Fating D R, Dandekar A K, Tirpude N, Role of IV Nalbuphine in attenuation of haemodynamic response to laryngoscopy and endotracheal intubation. Indian J Clin Anaesth 2016;3(2):165-169


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.